My bad, I was still thinking of yesterdays's thread content about how reagent is a forced subscription model etc. Was biased. I do agree with your post regarding GHL having the R&D budget and experience to do ionic probes well.
There is also Xepta going the route of ionic probes, but I have not heard anything in months and months about their progress.
No worries, I just really didn't want to see what I said lead down the whole subscription rabbit hole the thread seems to flirt with daily lol
I haven't heard much about Xepta either which is why I sort-of left them out of the convo. They are new to the scene and who knows if things will pan out for them. I hope so, but in today's market it might be a long road.


. T

